© 1993 British Society for Rheumatology
research-article |
RANITIDINE IN THE TREATMENT OF GASTRIC AND DUODENAL ULCERS ASSOCIATED WITH NON-STEROIDAL ANTI INFLAMMATORY DRUGS

,
*Hartlepool General Hospital Hartlepool, Cleveland TS24 9AH
Departrnent of Gastroenterology, Glaxo Group Research Limited Greenford, Middlesex UB6 0HE
Correspondence to:
Correspondence to J. R. Wood
To assess the effect of 4 weeks' therapy with ranitidine 150 mg twice daily on the healing of symptomatic NSAID associated gastric and duodenal ulcers, 149 arthritic patients were randomly allocated to one of three treatment groups: ranitidine with NSAID continued, ranitidine with NSAID discontinued, and placebo with NSAID discontinued. The healing frequency in patients with gastric ulceration was 67, 68 and 47%, and in those with duodenal ulceration 61, 81 and 42%, respectively. Only the difference between the duodenal ulcer healing rates for ranitidine with NSAID discontinued and placebo was statistically significant (P=0.02). Healing rates were uninfluenced by gender, age, smoking habits, alcohol consumption, ulcer frequency or size, arthritic disease, or participating country.
KEY WORDS: Non-steroidal anti-inflammatory drug-associated ulcers, Ulcer healing, Ranitidine